Hematopoietic Neoplasm Clinical Trial
Official title:
UF-BMT-HSCT-001: A Non-Interventional Study Evaluating the Quality of Diet in Allogeneic and Autologous Hematopoietic Stem Cell Transplant Survivors
This is a single center, cross-sectional, non-interventional study aimed at the nutritional intake of long-term health of allogeneic or autologous hematopoietic stem cell transplant (HSCT) survivors.
Higher rates of comorbidity among hematopoietic stem cell transplant (HSCT) survivors support the need for lifestyle interventions that target this vulnerable population. Comprehensive evaluation of the nutrient intake will provide adequate information necessary for develop of a targeted nutritional intervention in order to achieve specific nutritional need and improve long-term health of HSCT survivors. The cross-sectional design of this study has been selected for the timely collection of subject reported nutrient intake data. The intended study is strictly observational. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04622956 -
GVHD Prophylaxis With Methotrexate in Haploidentical HCT Using Posttransplant Cyclophosphamide
|
Phase 1/Phase 2 | |
| Completed |
NCT01420783 -
Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia
|
Phase 2 | |
| Recruiting |
NCT05759975 -
Effectiveness of Extraoral Photobiomodulation in Management of Oral Adverse Effects in Patients Undergoing HSCT
|
N/A | |
| Completed |
NCT01437787 -
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
|
Phase 3 | |
| Completed |
NCT01420770 -
Phase 2 Study of SAR302503 in Patients With Myelofibrosis
|
Phase 2 | |
| Completed |
NCT01523171 -
Phase II, Open Label, Single Arm Study of SAR302503 In Myelofibrosis Patients Previously Treated With Ruxolitinib
|
Phase 2 |